Chardan Trims Price Target on Pear Therapeutics to $8 From $9 on Headcount Reduction, Reiterates Buy Rating
Chardan Trims Price Target on Pear Therapeutics to $8 From $9 on Headcount Reduction, Reiterates Buy Rating
查尔丹将Pear Therapeutics的目标股价从裁员后的9美元下调至8美元，重申买入评级
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间